Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Selected Trial Populations Selected Trial Populations Clinical trials use eligibility criteria
Employer policy
1 The 2.4 mg dose of Wegovy produced an average weight loss of 14.9% over 68 weeks in the STEP 1 trial
The goal is to achieve good glycaemic control with minimal adverse effects, supporting long-term adherence and reducing diabetes-related complications
What Does Anthem Prior Authorization for GLP-1s Require
Available as prescription-strength Xenical and over-the-counter Alli (lower dose)
US$ 25.69
US$ 24.69
US$ 28.35
US$ 27.25
